4.4 Article

Non-coding RNAs: Identification of Cancer-Associated microRNAs by Gene Profiling

Journal

TECHNOLOGY IN CANCER RESEARCH & TREATMENT
Volume 9, Issue 2, Pages 123-138

Publisher

SAGE PUBLICATIONS INC
DOI: 10.1177/153303461000900202

Keywords

Non-coding RNA; Profiling; Cancer; MicroRNA; Expression analysis

Categories

Funding

  1. University of Texas M. D. Anderson Research Trust
  2. University of Texas System Regents Research Scholar
  3. Ladjevardian Regents Research Scholar Fund
  4. National Institutes of Health Department of Defense (DOD)
  5. Seena Magowitz - Pancreatic Cancer Action Network AACR Pilot
  6. Slovenian Research Agency [P4-0220, 30767]

Ask authors/readers for more resources

MicroRNAs (miRNAs) belong to the heterogeneous class of non-coding RNAs (ncRNAs), which are by definition RNA molecules that do not encode for proteins, but have instead important structural, catalytic or regulatory functions. In this review we first provide an overview of the different ncRNA families, focusing in particular on miRNAs and their relevance in tumour development and progression. Second we shortly describe the available ncRNA expression profiling methods, which comprise microarray, bead-based hybridization methods, in situ hybridization, quantitative real-time polymerase chain reaction, cloning and deep sequencing methods. Finally, we used the PubMed database to perform an extensive literature search for miRNA expression profiling research articles in cancer and identified 58 studies that were published between 2004 and 2009; we identified 70 miRNAs that were reported in at least five studies as being either up- or downregulated, depending on the type of cancer, and 192 miRNAs that were reported to be up- or downregulated in at least two reports. MiRNA expression profiling of human tumours has identified signatures associated with diagnosis, staging, progression, prognosis, and response to treatment. Based on the most important findings we discuss the possible use of miRNAs as clinical biomarkers in the management of cancer patients for diagnosis, prognosis, and response to therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available